These results support the concept that TG2 acts in part through an activation of PI3K/Akt signaling in A431 tumor cells that inhibits GSK-3β, and therefore upregulates Snail/MMP-9 and ultimately promotes EMT progression. This evidence concerns the gene SNAI1 and neoplasm.